CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $46,000 | -73.6% | 7,400 | -50.0% | 0.00% | -100.0% |
| Q2 2019 | $174,000 | +21.7% | 14,800 | +64.4% | 0.00% | 0.0% |
| Q1 2019 | $143,000 | +62.5% | 9,000 | +21.6% | 0.00% | 0.0% |
| Q4 2018 | $88,000 | -38.5% | 7,400 | -17.8% | 0.00% | 0.0% |
| Q3 2018 | $143,000 | -7.1% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $154,000 | -21.8% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | +55.1% | 9,000 | -6.2% | 0.00% | -50.0% |
| Q1 2016 | $127,000 | -39.2% | 9,600 | -13.5% | 0.00% | 0.0% |
| Q4 2015 | $209,000 | +2.0% | 11,100 | +1.8% | 0.00% | -33.3% |
| Q3 2015 | $205,000 | +31.4% | 10,900 | +3.8% | 0.00% | +50.0% |
| Q2 2015 | $156,000 | +9.9% | 10,500 | +11.7% | 0.00% | 0.0% |
| Q1 2015 | $142,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,817,138 | $30,582,000 | 2.98% |
| SENZAR ASSET MANAGEMENT, LLC | 29,821 | $502,000 | 1.45% |
| INGALLS & SNYDER LLC | 1,337,862 | $22,516,000 | 1.04% |
| Matarin Capital Management, LLC | 316,858 | $5,332,720,000 | 0.39% |
| KNOTT DAVID M | 51,557 | $868,000 | 0.32% |
| PRINCETON CAPITAL MANAGEMENT LLC | 16,582 | $279,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 123,700 | $2,082,000 | 0.10% |
| Spark Investment Management LLC | 97,200 | $1,635,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 941,282 | $15,841,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 67,220 | $1,131,000 | 0.06% |